These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 8589274)

  • 1. The in vivo effect of recombinant human interleukin-1 receptor antagonist on spleen colony forming cells after radiation induced myelosuppression.
    Milenkovíc P; Ivanovíc Z; Stosić-Grujicić S
    Eur Cytokine Netw; 1995; 6(3):177-80. PubMed ID: 8589274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of interleukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in normal mice.
    Jovcic G; Ivanovic Z; Biljanovic-Paunovic L; Bugarski D; Stosic-Grujicic S; Milenkovic P
    Eur Cytokine Netw; 1996; 7(1):71-4. PubMed ID: 8704098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of specific interleukin-1 receptor blockade on hematopoietic stem cell proliferation].
    Stosić-Grujicić S; Milenković P; Ivanović Z; Lukić M
    Srp Arh Celok Lek; 1994; 122 Suppl 1():13-4. PubMed ID: 18173175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of recombinant human interleukin-1 beta on the repopulation of bone-marrow colony-forming cells in mice subjected to the action of radiation and burns].
    Alekseeva LV; Izotova NI; Ketlinskiĭ SA; Pereverzev AE; Simbirtsev AS
    Tsitologiia; 1991; 33(3):88-94. PubMed ID: 1801379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II)2(3,5-diisopropylsalicylate)4 stimulates hemopoiesis in normal and irradiated mice.
    Soderberg LS; Barnett JB; Baker ML; Chang LW; Salari H; Sorenson JR
    Exp Hematol; 1988 Aug; 16(7):577-80. PubMed ID: 3292276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow.
    Jovcić G; Ivanović Z; Biljanović-Paunović L; Bugarski D; Stosić-Grujicić S; Milenković P
    Leukemia; 1996 Mar; 10(3):564-9. PubMed ID: 8642876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
    Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
    Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioprotection of mice with interleukin-1: relationship to the number of spleen colony-forming units.
    Schwartz GN; Patchen ML; Neta R; MacVittie TJ
    Radiat Res; 1989 Jul; 119(1):101-12. PubMed ID: 2787916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil.
    Neta R; Keller JR; Ali N; Blanchette F; Dubois CM
    Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
    Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of beta-interleukin on the content and proliferation of hemopoietic precursor cells in intact and irradiated long-term cultures of the bone marrow].
    Lebedev VG; Moroz BB; Deshevoĭ IuB
    Patol Fiziol Eksp Ter; 2002; (4):2-4. PubMed ID: 12638418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preiliminary studies on the efficacy and mechanism of interleukin-3 in the treatment of myelosuppression in mice].
    Chen J; Hu W; Zhao S; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 May; 13(2):134-7. PubMed ID: 10074234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit-ligand: implications for CFU-S as the responsible target cell population.
    van Os R; Lamont C; Witsell A; Mauch PM
    Exp Hematol; 1997 Mar; 25(3):205-10. PubMed ID: 9091295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioprotection of hemopoiesis conferred by Acanthopanax senticosus Harms (Shigoka) administered before or after irradiation.
    Miyanomae T; Frindel E
    Exp Hematol; 1988 Oct; 16(9):801-6. PubMed ID: 3049132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of hematopoietic colony-forming cells in irradiated mice pretreated with interleukin 1 (IL-1).
    Schwartz GN; Neta R; Vigneulle RM; Patchen ML; MacVittie TJ
    Exp Hematol; 1988 Oct; 16(9):752-7. PubMed ID: 3262530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of juzen-taiho-toh (TJ-48), a traditional Oriental medicine, on hematopoietic recovery from radiation injury in mice.
    Ohnishi Y; Yasumizu R; Fan HX; Liu J; Takao-Liu F; Komatsu Y; Hosoya E; Good RA; Ikehara S
    Exp Hematol; 1990 Jan; 18(1):18-22. PubMed ID: 2298264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF.
    Kovacs CJ; Evans MJ; Roberts C; Harrell J; Abernathy R; Gooya J; Johnke RM
    Exp Hematol; 1995 Aug; 23(9):1016-23. PubMed ID: 7635181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.